| Felicia Lynette Green, MHRS | |
|
109 Nw 2nd Ave, Visalia, CA 93291-3672 | |
| (559) 627-1490 | |
| (559) 627-1405 |
| Full Name | Felicia Lynette Green |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 109 Nw 2nd Ave, Visalia, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023252327 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Felicia Lynette Green, MHRS 711 N Court St Ste B, Visalia, CA 93291-3638 Ph: (559) 627-1490 | Felicia Lynette Green, MHRS 109 Nw 2nd Ave, Visalia, CA 93291-3672 Ph: (559) 627-1490 |
News Archive
Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, has purchased the cannulae product line from Estech.
Electronic nicotine delivery systems (ENDS), or e-cigarettes, debuted in China in 2003 and have since become available globally, particularly through the Internet. While they resemble traditional tobacco cigarettes, they produce fewer toxins in the vapor for the smoker. Still, these novel products have unknown long-term health and addiction consequences, are of varying nicotine content and delivery, and may appeal to nonusers and youth. ENDS have been banned by health authorities in Canada and Australia.
The U.S. Food and Drug Administration today approved an expanded indication that will allow a new group of patients at risk of stroke due to clogged neck arteries to be treated with the RX Acculink carotid stent.
New research conducted by the scientific director for VGTI Florida and his colleagues at the University of Montreal, in collaboration with scientists from the NIH and the McGill University Hospital center, may soon lead to an expansion of the drug arsenal used to fight HIV. The research sheds new light on how HIV gradually weakens the body's immune system and highlights the need for new research into therapies that will target the chain of events that cause the progression of the disease.
Array BioPharma Inc. today announced presentations on encorafenib, binimetinib and selumetinib (licensed to AstraZeneca) at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held May 29 – June 2, 2015 in Chicago, Illinois.
› Verified 4 days ago
Augustina Veronica Garcia, Counselor Medicare: Not Enrolled in Medicare Practice Location: 705 S Court St, Visalia, CA 93277 Phone: 559-635-8010 Fax: 559-635-1411 | |
Octaviana Rodriguez, Counselor Medicare: Not Enrolled in Medicare Practice Location: 6500 S. Mooney Blvd., Suite B, Visalia, CA 93277 Phone: 559-685-1200 | |
Donaciano Nunez, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3107 E Kaweah Ave, Visalia, CA 93292 Phone: 559-754-2705 Fax: 559-754-2708 | |
Sara Camacho, Counselor Medicare: Not Enrolled in Medicare Practice Location: 320 W Oak Ave, Visalia, CA 93291 Phone: 559-625-3420 | |
Spicey Onata Ruiz, RADT Counselor Medicare: Not Enrolled in Medicare Practice Location: 1425 E Walnut Ave, Visalia, CA 93292 Phone: 559-625-4072 | |
Annette Elizabeth Imperatrice Farmer, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1646 S Court St, Visalia, CA 93277 Phone: 559-625-8890 Fax: 550-733-5053 | |
Mike Marquez, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1646 S Court St, Visalia, CA 93277 Phone: 559-625-8890 |